Wedbush Securities’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$153K Buy
11,950
+200
+2% +$2.56K 0.01% 1082
2025
Q1
$149K Buy
+11,750
New +$149K 0.01% 1037
2024
Q4
Sell
-16,273
Closed -$245K 1165
2024
Q3
$245K Sell
16,273
-400
-2% -$6.02K 0.01% 904
2024
Q2
$236K Buy
16,673
+1,261
+8% +$17.8K 0.01% 987
2024
Q1
$210K Sell
15,412
-4,700
-23% -$64K 0.01% 1070
2023
Q4
$271K Sell
20,112
-2,624
-12% -$35.4K 0.01% 814
2023
Q3
$284K Buy
22,736
+3,000
+15% +$37.5K 0.01% 754
2023
Q2
$267K Buy
19,736
+1,724
+10% +$23.3K 0.01% 810
2023
Q1
$251K Buy
18,012
+1,250
+7% +$17.4K 0.01% 822
2022
Q4
$238K Buy
16,762
+2,450
+17% +$34.8K 0.01% 834
2022
Q3
$196K Buy
14,312
+318
+2% +$4.36K 0.01% 902
2022
Q2
$199K Buy
13,994
+824
+6% +$11.7K 0.01% 929
2022
Q1
$218K Buy
13,170
+2,975
+29% +$49.2K 0.01% 948
2021
Q4
$196K Buy
10,195
+109
+1% +$2.1K 0.01% 1062
2021
Q3
$210K Sell
10,086
-17
-0.2% -$354 0.01% 1042
2021
Q2
$217K Buy
+10,103
New +$217K 0.01% 1026
2019
Q2
Sell
-10,913
Closed -$187K 1011
2019
Q1
$187K Buy
+10,913
New +$187K 0.02% 792
2018
Q4
Sell
-11,707
Closed -$239K 882
2018
Q3
$239K Buy
+11,707
New +$239K 0.03% 686
2016
Q3
Sell
-10,104
Closed -$174K 842
2016
Q2
$174K Buy
+10,104
New +$174K 0.03% 648
2016
Q1
Sell
-12,059
Closed -$285K 775
2015
Q4
$285K Buy
12,059
+1,601
+15% +$37.8K 0.05% 426
2015
Q3
$235K Sell
10,458
-589
-5% -$13.2K 0.05% 465
2015
Q2
$312K Buy
11,047
+2,105
+24% +$59.5K 0.06% 412
2015
Q1
$247K Buy
+8,942
New +$247K 0.04% 495